Gyre Therapeutics Stock (NASDAQ:CBIO)
Previous Close
$12.55
52W Range
$10.83 - $63.00
50D Avg
$13.32
200D Avg
$21.59
Market Cap
$173.52M
Avg Vol (3M)
$107.08K
Beta
-
Div Yield
-
CBIO Company Profile
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.